New World Advisors’s Gilead Sciences GILD Stock Holding History

New World Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,200	Closed	-$78K	–	50
2019 Q1	$78K	Buy	+1,200	New	+$79.8K	0.06%	39

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

New World Advisors's GILD Position: Q2 2019 in Review

New World Advisors sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 1,200 shares — an estimated $78K sold.

New World Advisors first reported a position in GILD in Q1 2019 and held it in 1 quarter. The position peaked at $78K in Q1 2019. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

New World Advisors reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
New World Advisors sold 1,200 Gilead Sciences shares in Q2 2019, an estimated $78K.
New World Advisors first reported a position in Gilead Sciences in Q1 2019 and held it in 1 quarter.
New World Advisors's Gilead Sciences position peaked at $78K in Q1 2019.
1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on New World Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.